Inhibition Ability of Natural Compounds on Receptor-Binding Domain of SARS-CoV2: An In Silico Approach

The lack of medication to treat COVID-19 is still an obstacle that needs to be addressed by all possible scientific approaches. It is essential to design newer drugs with varied approaches. A receptor-binding domain (RBD) is a key part of SARS-CoV-2 virus, located on its surface, that allows it to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Nedyalkova, Miroslava, Vasighi, Mahdi, Sappati, Subrahmanyam, Kumar, Anmol, Madurga, Sergio, Simeonov, Vasil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704597/
https://www.ncbi.nlm.nih.gov/pubmed/34959727
http://dx.doi.org/10.3390/ph14121328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704597/
https://www.ncbi.nlm.nih.gov/pubmed/34959727
http://dx.doi.org/10.3390/ph14121328

Ejemplares similares